COVID 19 peptide catalog

Sars-CoV-2 is a Betacoronavirus responsible for the COVID-19 respiratory outbreak. Via a human-to-human transmission, the virus is known to be very aggressive and has now infected more than 13 million around the world and caused the deaths of more than ½ million people (data from July 15, 2020).

Research is crucial to find therapeutic, diagnostic and prophylactit solutions. Proteins of SARS-COV-2 virus are well identified, characterized and are considered as good targerts for developing new therapies. Therefore, sb-PEPTIDE provides a broad range of services including COVID-19 related peptides, COVID-19 proteins under libraries formats and custom synthesis services.

Sars-CoV-2 / COVID-19 peptide libraries and variants

Some Sars-CoV-2 proteins are identified as leading targets for COVID-19 therapies. sb-PEPTIDE offers a catalog of peptide libraries of different viral proteins such as Spike S protein, Nucleocapsid N protein and Membrane M protein. sb-PEPTIDE can also synthesize upon request other specific libraries (see peptide library synthesis section).

SB-PEPTIDE also offers a special pack including peptides from COVID-19 variants : UK COVID-19 variant B.1.1.7, South Africa COVID-19 variant B.1.351, Brazil COVID-19 variant B.1.1.248.

COVID-19 peptides

sb-PEPTIDE offers SARS-CoV-2 Spike RBD and RBM peptides and some COVID-19 related peptides and is able to custom synthesize specific peptides upon request (visit peptide synthesis section).